It was the first in a series of drugs that are, for the first time, effective against obesity and can help lessen the moral ...

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session on India Today Conclave 2025, said that many celebrities may not want to admit to taking Ozempic ...

A LOVED-UP mum’s bid to shine in her wedding dress went wrong after using a pharmacy-bought ‘fat jab’. Stephanie Hill decided to purchase a weight-loss injectable from an online ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side effects of Ozempic during a ...

Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Novo Nordisk got the green light to join a lawsuit by compounders against the FDA after the agency deemed that the Danish ...

Novo Nordisk is introducing a direct-to-patient delivery option for its flagship weight loss drug Wegovy (semaglutide), ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...